Ironwood Pharmaceuticals (IRWD)
Add to Watchlists Create an Alert
12.52
-0.39 -3.02%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Ironwood Pharmaceuticals SG&A Expense Quarterly:
58.10M for March 31, 2013Ironwood Pharmaceuticals Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 58.10M |
| Dec. 31, 2012 | 41.64M |
| Sept. 30, 2012 | 25.35M |
| June 30, 2012 | 23.20M |
| March 31, 2012 | 18.37M |
| Dec. 31, 2011 | 14.96M |
| Sept. 30, 2011 | 10.93M |
| June 30, 2011 | 10.80M |
| March 31, 2011 | 9.224M |
| Dec. 31, 2010 | 8.301M |
| Sept. 30, 2010 | 6.482M |
| June 30, 2010 | 6.601M |
| March 31, 2010 | 5.785M |
| Dec. 31, 2009 | 5.589M |
| Sept. 30, 2009 | 4.941M |
| June 30, 2009 | 5.79M |
| March 31, 2009 | 5.194M |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
IRWD SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Forest Laboratories | 372.73M |
| Valeant Pharmaceuticals International | 246.35M |
| Synergy Pharmaceuticals | 2.448M |
IRWD SG&A Expense Quarterly Rankings
| Overall |
82nd percentile 1408 of 8009 |
| Sector |
81st percentile 124 of 687 in Healthcare |
| Industry |
76th percentile 15 of 65 in Diagnostics & Research |
IRWD SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 4.941M | Sep 2009 |
| Maximum | 58.10M | Mar 2013 |
| Average | 15.37M |
